Parasitaemia and fever in uncomplicated Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.
PLoS Negl Trop Dis.
2025 Mar;19(3):e0012951. doi: 10.1371/journal.pntd.0012951. eCollection 2025 Mar. Review. PubMed PMID:
40153391; PubMed Central PMCID:
PMC11978046.
Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis.
PLoS Negl Trop Dis.
2025 Mar;19(3):e0012864. doi: 10.1371/journal.pntd.0012864. eCollection 2025 Mar. PubMed PMID:
40132008; PubMed Central PMCID:
PMC11936200.
Evaluation of CareStart™ malaria HRP2/pLDH (Pf/PAN) combo rapid diagnostic test for diagnosis of Plasmodium falciparum infection in malaria co-endemic areas in association with parasite density.
Malar J.
2025 Feb 10;24(1):39. doi: 10.1186/s12936-025-05276-y. PubMed PMID:
39930468; PubMed Central PMCID:
PMC11812152.
Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics.
Lancet Infect Dis.
2025 Jan 13;. doi: 10.1016/S1473-3099(24)00689-3. [Epub ahead of print] PubMed PMID:
39818221.
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.
Lancet Child Adolesc Health.
2024 Nov;8(11):798-808. doi: 10.1016/S2352-4642(24)00210-4. Epub 2024 Sep 24. PubMed PMID:
39332427; PubMed Central PMCID:
PMC11480364.
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.
PLoS Med.
2024 Sep;21(9):e1004411. doi: 10.1371/journal.pmed.1004411. eCollection 2024 Sep. PubMed PMID:
39331646; PubMed Central PMCID:
PMC11469483.
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites.
Nat Commun.
2024 Aug 8;15(1):6757. doi: 10.1038/s41467-024-51015-3. PubMed PMID:
39117628; PubMed Central PMCID:
PMC11310204.
Implementation of Glucose-6-Phosphate Dehydrogenase (G6PD) testing for Plasmodium vivax case management, a mixed method study from Cambodia.
PLOS Glob Public Health.
2024;4(7):e0003476. doi: 10.1371/journal.pgph.0003476. eCollection 2024. PubMed PMID:
39028699; PubMed Central PMCID:
PMC11259306.
Chloroquine has shown high therapeutic efficacy against uncomplicated Plasmodium vivax malaria in southern Ethiopia: seven decades after its introduction.
Malar J.
2024 Jun 10;23(1):183. doi: 10.1186/s12936-024-05009-7. PubMed PMID:
38858696; PubMed Central PMCID:
PMC11165762.
Progress towards safer and more effective radical cure of Plasmodium vivax.
Lancet Infect Dis.
2024 Jun;24(6):565-567. doi: 10.1016/S1473-3099(24)00139-7. Epub 2024 Mar 4. PubMed PMID:
38452775.
The PreQuine Platform: A novel diagnostic tool for measuring glucose-6-phosphate dehydrogenase (G6PD) activity and hemoglobin concentration.
PLoS One.
2024;19(5):e0297918. doi: 10.1371/journal.pone.0297918. eCollection 2024. PubMed PMID:
38728310; PubMed Central PMCID:
PMC11086878.
Field evaluation of a novel semi-quantitative point-of-care diagnostic for G6PD deficiency in Indonesia.
PLoS One.
2024;19(4):e0301506. doi: 10.1371/journal.pone.0301506. eCollection 2024. PubMed PMID:
38687748; PubMed Central PMCID:
PMC11060553.
Imported malaria into Australia: surveillance insights and opportunities.
J Travel Med.
2024 Apr 6;31(3). doi: 10.1093/jtm/taad164. PubMed PMID:
38127641; PubMed Central PMCID:
PMC10998534.
Evidence uptake is only part of the process: Stakeholders' insights on WHO treatment guideline recommendation processes for radical cure of P. vivax malaria.
PLOS Glob Public Health.
2024;4(3):e0002990. doi: 10.1371/journal.pgph.0002990. eCollection 2024. PubMed PMID:
38483936; PubMed Central PMCID:
PMC10939226.
A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.
Trials.
2024 Feb 29;25(1):154. doi: 10.1186/s13063-024-07987-0. PubMed PMID:
38424577; PubMed Central PMCID:
PMC10905854.
Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'.
Elife.
2024 Feb 7;13. doi: 10.7554/eLife.91283. PubMed PMID:
38323801; PubMed Central PMCID:
PMC10849674.
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis.
Lancet Infect Dis.
2024 Feb;24(2):184-195. doi: 10.1016/S1473-3099(23)00431-0. Epub 2023 Sep 22. PubMed PMID:
37748497; PubMed Central PMCID:
PMC7615565.
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis.
Lancet Infect Dis.
2024 Feb;24(2):172-183. doi: 10.1016/S1473-3099(23)00430-9. Epub 2023 Sep 22. PubMed PMID:
37748496; PubMed Central PMCID:
PMC7615564.
Retention of uninfected red blood cells causing congestive splenomegaly is the major mechanism of anemia in malaria.
Am J Hematol.
2024 Feb;99(2):223-235. doi: 10.1002/ajh.27152. Epub 2023 Nov 27. PubMed PMID:
38009287; PubMed Central PMCID:
PMC10952982.
Field assessment of the operating procedures of a semi-quantitative G6PD Biosensor to improve repeatability of routine testing.
PLoS One.
2024;19(1):e0296708. doi: 10.1371/journal.pone.0296708. eCollection 2024. PubMed PMID:
38241389; PubMed Central PMCID:
PMC10798449.
Safety and efficacy of primaquine in patients with Plasmodium vivax malaria from South Asia: a systematic review and individual patient data meta-analysis.
BMJ Glob Health.
2023 Dec 20;8(12). doi: 10.1136/bmjgh-2023-012675. PubMed PMID:
38123228; PubMed Central PMCID:
PMC10749047.
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
Lancet.
2023 Dec 2;402(10417):2101-2110. doi: 10.1016/S0140-6736(23)01553-2. Epub 2023 Nov 15. PubMed PMID:
37979594; PubMed Central PMCID:
PMC10714037.
Genomic analysis of Plasmodium vivax describes patterns of connectivity and putative drivers of adaptation in Ethiopia.
Sci Rep.
2023 Nov 27;13(1):20788. doi: 10.1038/s41598-023-47889-w. PubMed PMID:
38012191; PubMed Central PMCID:
PMC10682486.
Genomics of Plasmodium vivax in Colombia reveals evidence of local bottle-necking and inter-country connectivity in the Americas.
Sci Rep.
2023 Nov 13;13(1):19779. doi: 10.1038/s41598-023-46076-1. PubMed PMID:
37957271; PubMed Central PMCID:
PMC10643449.
The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region.
Lancet Glob Health.
2023 Nov;11(11):e1805-e1818. doi: 10.1016/S2214-109X(23)00415-1. Review. PubMed PMID:
37858590.
Clinical performance validation of the STANDARD G6PD test: A multi-country pooled analysis.
PLoS Negl Trop Dis.
2023 Oct;17(10):e0011652. doi: 10.1371/journal.pntd.0011652. eCollection 2023 Oct. PubMed PMID:
37824592; PubMed Central PMCID:
PMC10597494.
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Malar J.
2023 Oct 10;22(1):306. doi: 10.1186/s12936-023-04725-w. PubMed PMID:
37817240; PubMed Central PMCID:
PMC10563365.
Severe Hemolysis during Primaquine Radical Cure of Plasmodium vivax Malaria: Two Systematic Reviews and Individual Patient Data Descriptive Analyses.
Am J Trop Med Hyg.
2023 Oct 4;109(4):761-769. doi: 10.4269/ajtmh.23-0280. Print 2023 Oct 4. PubMed PMID:
37604475; PubMed Central PMCID:
PMC10551063.
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
PLoS Negl Trop Dis.
2023 Sep;17(9):e0011522. doi: 10.1371/journal.pntd.0011522. eCollection 2023 Sep. PubMed PMID:
37672548; PubMed Central PMCID:
PMC10482257.
The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial.
BMC Med Res Methodol.
2023 Sep 4;23(1):198. doi: 10.1186/s12874-023-02022-3. PubMed PMID:
37667204; PubMed Central PMCID:
PMC10476314.
A model for malaria treatment evaluation in the presence of multiple species.
Epidemics.
2023 Sep;44:100687. doi: 10.1016/j.epidem.2023.100687. Epub 2023 May 18. PubMed PMID:
37348379; PubMed Central PMCID:
PMC7614843.
No Association between the Plasmodium vivax crt-o MS334 or In9pvcrt Polymorphisms and Chloroquine Failure in a Pre-Elimination Clinical Cohort from Malaysia with a Large Clonal Expansion.
Antimicrob Agents Chemother.
2023 Jul 18;67(7):e0161022. doi: 10.1128/aac.01610-22. Epub 2023 Jun 14. PubMed PMID:
37314336; PubMed Central PMCID:
PMC10353443.
Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis.
Malar J.
2023 Jun 6;22(1):174. doi: 10.1186/s12936-023-04583-6. PubMed PMID:
37280686; PubMed Central PMCID:
PMC10243075.
Adapting international clinical trials during COVID-19 and beyond.
Clin Trials.
2023 Jun;20(3):237-241. doi: 10.1177/17407745231154215. Epub 2023 Feb 11. PubMed PMID:
36772825; PubMed Central PMCID:
PMC9922661.
Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study.
Malar J.
2023 May 20;22(1):162. doi: 10.1186/s12936-023-04578-3. PubMed PMID:
37210520; PubMed Central PMCID:
PMC10199529.
Imported malaria and its implication to achievement of malaria-free Bhutan.
J Travel Med.
2023 May 18;30(3). doi: 10.1093/jtm/taad044. PubMed PMID:
37014773.
A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria.
Pathogens.
2023 Apr 27;12(5). doi: 10.3390/pathogens12050650. Review. PubMed PMID:
37242320; PubMed Central PMCID:
PMC10220632.
Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function.
Am J Trop Med Hyg.
2023 Jan 11;108(1):76-80. doi: 10.4269/ajtmh.21-0834. Print 2023 Jan 11. PubMed PMID:
36509054; PubMed Central PMCID:
PMC9833077.
A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria.
Commun Biol.
2022 Dec 23;5(1):1411. doi: 10.1038/s42003-022-04352-2. PubMed PMID:
36564617; PubMed Central PMCID:
PMC9789135.
The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis.
Elife.
2022 Dec 6;11. doi: 10.7554/eLife.83433. PubMed PMID:
36472067; PubMed Central PMCID:
PMC9725750.
Relationship of circulating Plasmodium falciparum lifecycle stage to circulating parasitemia and total parasite biomass.
Nat Commun.
2022 Sep 23;13(1):5557. doi: 10.1038/s41467-022-32996-5. PubMed PMID:
36151085; PubMed Central PMCID:
PMC9508081.
Safety of single-dose primaquine as a Plasmodium falciparum gametocytocide: a systematic review and meta-analysis of individual patient data.
BMC Med.
2022 Sep 16;20(1):350. doi: 10.1186/s12916-022-02504-z. PubMed PMID:
36109733; PubMed Central PMCID:
PMC9479278.
Genetic Variants of Glucose-6-Phosphate Dehydrogenase and Their Associated Enzyme Activity: A Systematic Review and Meta-Analysis.
Pathogens.
2022 Sep 14;11(9). doi: 10.3390/pathogens11091045. Review. PubMed PMID:
36145477; PubMed Central PMCID:
PMC9502867.
Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria.
Malar J.
2022 Sep 6;21(1):255. doi: 10.1186/s12936-022-04268-6. PubMed PMID:
36068577; PubMed Central PMCID:
PMC9446641.
Heterogeneity in prevalence of subclinical Plasmodium falciparum and Plasmodium vivax infections but no parasite genomic clustering in the Chittagong Hill Tracts, Bangladesh.
Malar J.
2022 Jul 14;21(1):218. doi: 10.1186/s12936-022-04236-0. PubMed PMID:
35836171; PubMed Central PMCID:
PMC9281141.
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity.
PLoS Negl Trop Dis.
2022 Jun;16(6):e0010492. doi: 10.1371/journal.pntd.0010492. eCollection 2022 Jun. PubMed PMID:
35737709; PubMed Central PMCID:
PMC9258880.
Intermittent screening and treatment for malaria complementary to routine immunisation in the first year of life in Papua, Indonesia: a cluster randomised superiority trial.
BMC Med.
2022 Jun 8;20(1):190. doi: 10.1186/s12916-022-02394-1. PubMed PMID:
35672703; PubMed Central PMCID:
PMC9175359.
Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas-a randomized controlled trial (PRIMA).
Trials.
2022 May 18;23(1):416. doi: 10.1186/s13063-022-06364-z. PubMed PMID:
35585641; PubMed Central PMCID:
PMC9116071.
Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria.
PLoS Negl Trop Dis.
2022 May;16(5):e0010406. doi: 10.1371/journal.pntd.0010406. eCollection 2022 May. PubMed PMID:
35544453; PubMed Central PMCID:
PMC9094517.
Malaria eradication revisited.
Int J Epidemiol.
2022 May 9;51(2):382-392. doi: 10.1093/ije/dyab259. PubMed PMID:
34918106.
What would you like to do?